Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Molecular Targeting Probes - Radioactive & Nonradioactive

  • You have access
    N-(Maleimidoethyl)-3-(guanidinomethyl)-5-[131I]iodobenzmide ([131I]MEGMIB): A Residualizing Prosthetic Agent for Site-Specific Radioiodination of Internalizing Single Domain Antibody Fragments.
    Yutian Feng, Zhengyuan Zhou, Darryl McDougald, Ganesan Vaidyanathan and Michael Zalutsky
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 581;
  • You have access
    In vitro response of 177Lu-PSMA-617 with two different specific activities
    Cristian Wieczorek Villas Boas, Jair Mengatti, Priscila Passos, Daniel Vieira and Elaine Bortoleti de Araujo
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 624;
  • You have access
    Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors
    Jiyun SUN, Zhen Chen, Jiahui Chen, Hualong Fu, Tuo Shao, Lu WANG, Hao Xu, Ming-Rong Zhang and Steven Liang
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 616;
  • You have access
    Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
    Yoshihiro Murakami, Yuji Fujita and Hiroshi Fushiki
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 617;
  • You have access
    A Unique 18F-labeled G-protein-coupled receptor 44 (GPR44) radiotracer: design, radio-synthesis and evaluation in the rodents
    Jiangling Peng, Wei Tang, Lynn Miao, Eryun Zhang, Nelson Gonzalez, Fouad Kandeel and Junfeng Li
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 622;
  • You have access
    18F-Radiofluorination of Aryl C-H Bonds using a Tandem Ir C-H Borylation/Cu Radiofluorination Strategy
    Jay Wright, Liam Sharninghausen, Sean Preshlock, Allen Brooks, Melanie Sanford and Peter Scott
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 585;
  • You have access
    Predictive modeling of tau aggregation and propagation using PET and DTI
    Fan Yang, Samadrita Chowdhury, Heidi Jacobs, Keith Johnson and Joyita Dutta
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 603;
  • You have access
    Design of calcium-sensing receptor targeted thera(g)nostic agents
    Xiaonan Deng, Weiping Yu, Mingyong Li, Cassandra Miller, Yao Xin, Matthew Goodman, Jian Hu, Mark Goodman and Jenny Yang
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 618;
  • You have access
    Grade and IDH genotype prediction in glioma by a hybrid PET/MR with FET-PET and DSC-PWI
    Shuangshuang Song and Jie Lu
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 596;
  • You have access
    Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
    Karla Ramos-Torres, Yu-Peng Zhou, Bo Yeun Yang, Nicolas Guehl, Sanjay Telu, Marc Normandin, Victor Pike and Pedro Brugarolas
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 619;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 101
SNMMI

© 2025 SNMMI

Powered by HighWire